İsmail Gülaçar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
İsmail Gülaçar has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Can Ateş
Ankara University School of Medicine, Department of Biostatistics, Ankara, Turkey
1 shared publication - Gokhan Gorgisen
Department of Medical Biology, Gülhane Medical School, University of Health Sciences, Ankara, Turkey
1 shared publication Gözde Yeşi̇l Sayin
İSTANBUL ÜNİVERSİTESİ, İSTANBUL TIP FAKÜLTESİ, DAHİLİ TIP BİLİMLERİ BÖLÜMÜ, TIBBİ GENETİK ANABİLİM DALI
1 shared publication- Necat Almalı
Faculty of Medicine, Department of General Surgery, Van Yuzuncu Yıl University, Van, Turkey
1 shared publication - Zehra Kaya
Department of Medical Biology, Faculty of Medicine, Van Yuzuncu Yil University, Van, Turkey
1 shared publication
Latest Publications
- Open Access
- 30 December 2021
- Published by Van Yuzuncu Yil University in Van Sağlık Bilimleri Dergisi
- Vol. 14 (3) , 298-303
No Association Between IRS2 Gly1057Asp Polymorphism and Esophageal Cancer
Introduction: The aim of this study was to figure out the relationship between IRS2 Gly1057Asp variant and susceptibility to esophageal cancer. Material and Methods: A case-control study was conducted to select 70 esophageal cancer patients and 100 healthy control samples. Genomic DNA was extracted from peripheral whole blood samples and real time polymerase chain reaction (RT-PCR) based SNP genotyping was performed using predesigned Taqman assay. Results: There was no significant difference in the frequency distribution of genotypes between patients and control group. Conclusion: There is no significant correlation between the IRS2 Gly1057Asp variant and the risk of esophageal cancer.
- 30 December 2021
- Published by Van Yuzuncu Yil University in Van Sağlık Bilimleri Dergisi
- Vol. 14 (3) , 298-303
Open AccessNo Association Between IRS2 Gly1057Asp Polymorphism and Esophageal Cancer
Introduction: The aim of this study was to figure out the relationship between IRS2 Gly1057Asp variant and susceptibility to esophageal cancer. Material and Methods: A case-control study was conducted to select 70 esophageal cancer patients and 100 healthy control samples. Genomic DNA was extracted from peripheral whole blood samples and real time polymerase chain reaction (RT-PCR) based SNP genotyping was performed using predesigned Taqman assay. Results: There was no significant difference in the frequency distribution of genotypes between patients and control group. Conclusion: There is no significant correlation between the IRS2 Gly1057Asp variant and the risk of esophageal cancer.